Who Paid My Doc
Douglas Mann
Cardiovascular Disease Saint Louis, MO Medical Doctor
NPI 1801807763 CMS profile 172637
4921 Parkview Pl, Div Im Cardiology, Ste 8B, Saint Louis, MO 63110
General payments
$50,034
Research payments
$1,746
Ownership & investment interest
$0
Through program year 2024, Douglas Mann of Saint Louis, MO is reported in the CMS Open Payments database as having received $50,034 across 27 general payments and $1,746 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 94th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $3,386 | 3 | |
| 2023 | General | $3,213 | 2 | |
| 2022 | General | $20,152 | 8 | |
| 2021 | General | $10,885 | 7 | |
| 2020 | General | $5,250 | 2 | |
| 2019 | General | $7,149 | 5 | |
| 2019 | Research | $1,746 | 1 |
Beside peers
- Douglas Mann
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Douglas Mann were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Douglas Mann | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,149 | $450 | $127–$1,392 | $163 |
| 2020 | $5,250 | $242 | $77–$751 | $114 |
| 2021 | $10,885 | $335 | $101–$1,037 | $132 |
| 2022 | $20,152 | $395 | $121–$1,211 | $149 |
| 2023 | $3,213 | $443 | $136–$1,283 | $160 |
| 2024 | $3,386 | $450 | $136–$1,323 | $164 |
| 2025 | $0 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
110
Drug cost
$21,698
Branded share of claims
35.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | Brand | 12 | $13,912 | |
| Eliquis Apixaban | Brand | 15 | $6,035 | |
| Kapspargo Sprinkle Metoprolol Succinate | Brand | 12 | $761 | |
| Atorvastatin Calcium | Generic | 29 | $446 | |
| Eplerenone | Generic | 11 | $272 | |
| Metoprolol Succinate | Generic | 17 | $184 | |
| Spironolactone | Generic | 14 | $89 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$2,987
Medicare patients
25
Services billed
58
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 60% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
28 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in Missouri
Mikhail Kosiborod
Cardiovascular Disease · Kansas City, MO
Georges Chahoud
Cardiovascular Disease · Saint Louis, MO
William Bowen
Cardiovascular Disease · Saint Louis, MO
Daniel Kelly
Cardiovascular Disease · Saint Louis, MO
John Spertus
Cardiovascular Disease · Kansas City, MO
James Fairlamb
Cardiovascular Disease · Columbia, MO
Related records
Cardiovascular Disease in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.